EP3426631A1 - Aqueous n-acyl amino acid solutions - Google Patents
Aqueous n-acyl amino acid solutionsInfo
- Publication number
- EP3426631A1 EP3426631A1 EP17707498.6A EP17707498A EP3426631A1 EP 3426631 A1 EP3426631 A1 EP 3426631A1 EP 17707498 A EP17707498 A EP 17707498A EP 3426631 A1 EP3426631 A1 EP 3426631A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- solution
- aqueous solution
- acyl
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000012535 impurity Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 50
- 239000007864 aqueous solution Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 15
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 13
- 229940051368 capryloyl glycine Drugs 0.000 claims description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- 229960002446 octanoic acid Drugs 0.000 claims description 5
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 238000010533 azeotropic distillation Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- ACXGEQOZKSSXKV-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCC(O)=O ACXGEQOZKSSXKV-UHFFFAOYSA-N 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 230000009036 growth inhibition Effects 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 238000001256 steam distillation Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 abstract description 18
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 7
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 35
- 229940024606 amino acid Drugs 0.000 description 31
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 239000000047 product Substances 0.000 description 21
- 239000000203 mixture Substances 0.000 description 19
- 235000001014 amino acid Nutrition 0.000 description 18
- 235000002639 sodium chloride Nutrition 0.000 description 15
- 239000002994 raw material Substances 0.000 description 12
- 239000003755 preservative agent Substances 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- -1 carboxylic acid chlorides Chemical class 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- AIXMJTYHQHQJLU-UHFFFAOYSA-N chembl210858 Chemical compound O1C(CC(=O)OC)CC(C=2C=CC(O)=CC=2)=N1 AIXMJTYHQHQJLU-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000001840 Dandruff Diseases 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 240000007582 Corylus avellana Species 0.000 description 3
- 235000007466 Corylus avellana Nutrition 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000002781 deodorant agent Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 101100295884 Aedes aegypti SGPRor7 gene Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000001543 Corylus americana Nutrition 0.000 description 2
- 108010008488 Glycylglycine Proteins 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 241000555688 Malassezia furfur Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 101150041122 Orco gene Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000001124 arachidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003910 behenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001734 carboxylic acid salts Chemical class 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 229940125532 enzyme inhibitor Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229940043257 glycylglycine Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- IEDIKTABXQYWBL-UHFFFAOYSA-N 3-aminopropanoic acid Chemical compound NCCC(O)=O.NCCC(O)=O IEDIKTABXQYWBL-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- HEUQYIQQCNOXOG-UHFFFAOYSA-N N-undecanoylglycine Chemical compound CCCCCCCCCCC(=O)NCC(O)=O HEUQYIQQCNOXOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000221095 Simmondsia Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008407 cosmetic solvent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 125000001381 docosenoyl group Chemical group O=C([*])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 125000000628 margaroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000016 octadecenoyl group Chemical group O=C([*])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Definitions
- the invention relates to a process for the preparation of aqueous solutions of / V-acyl-amino acids.
- the process does not require isolation of a solid and gives solutions with a low content of impurities.
- the invention comprises the corresponding aqueous solutions of / V-acyl-amino acids, and their use in cosmetic and pharmaceutical preparations.
- Capryloylglycine (I) is commercially available under the trade name "Caprocine” from MINASOLVE.Capryloylglycine has a broad antimicrobial activity against bacteria, fungi and yeasts.The substance can be used as a preservative and as a deodorant.In addition, capryloylglycine effectively inhibits the growth of The substance also inhibits the growth of the yeast Malassezia Furfur (Pityrosporum ovale), which contributes to the formation of dandruff on the scalp, and inhibits the enzyme 5-alpha reductase, Propionibacterium acnes, which is responsible for the development of acne.
- capryloylglycine can reduce sebum production in the skin, reducing the tendency to develop dandruff and acne / V acyl amino acids are generally low in toxicity and well tolerated by the skin is her application interesting in cosmetic and pharmaceutical products.
- / V-acyl amino acids are usually solids that are only moderately soluble in water.
- / V-acyl amino acids are therefore neutralized with the aid of bases and thus converted into their water-soluble carboxylic acid salts.
- strongly corrosive basic substances are often used. applies, for example, sodium hydroxide or potassium hydroxide.
- the strong bases are not compatible with all raw materials used in cosmetic or pharmaceutical preparations.
- the neutralization of the / V-acyl amino acids may need to be carried out in a separate stirred vessel.
- / V-acyl amino acids are dissolved in hot water or in another lipophilic solvent.
- the free / V-acyl amino acid causes a lowering of the pH in the formulation. This may also affect the stability of a formulation.
- the handling of solids is associated with disadvantages. In general, it must be ensured by means of long stirring times that the solid has completely dissolved in the chosen solvent. Furthermore, it may lead to dust, the z. B. leads to irritation of the skin, eyes and / or respiratory tract. If necessary, it also leads to a contamination of the working environment. Overall, the use of solid / V-acyl amino acids is associated with an increased time, energy, material, and thus costs.
- / V-acyl amino acids are prepared by condensation of amino acids with carboxylic acid chlorides or anhydrides in alkaline aqueous solution (Schotten-Baumann reaction). Examples of such syntheses are described in the literature, inter alia in FR 2771632 A1 (SEPPIC, priority: 01.12.1997) and WO2006 / 010590 A1 (Sinerga, priority: 30.07.2004).
- SEPPIC SEPPIC
- WO2006 / 010590 A1 Sinerga, priority: 30.07.2004
- As a result of the chemical reaction results in a basic crude product solution, in addition to the / V-acyl-amino acid salt at least one inorganic salt such.
- sodium chloride (NaCl) in equimolar amount.
- this non-purified aqueous / V-acyl amino acid solution can already be used as a raw material for cosmetic or pharmaceutical products.
- the disadvantage is that the inorganic salts contained in the solution can interact with other components of a formulation. For example, such salts can affect the rheology of an emulsion or gel.
- Another disadvantage is the presence of free alkyl carboxylic acids in the crude product solution. Alkylcarboxylic acids are a by-product of the Schotten-Baumann synthesis which arise as a result of hydrolysis of the activated carboxylic acid. Depending on the length of their carbon chain alkylcarboxylic acids can irritate the skin and have a characteristic, inappropriate odor.
- Another drawback with the direct application of the non-purified / V-acyl-amino acid solutions in cosmetics is the occasional staining.
- reaction mixtures obtained as described above are therefore further worked up.
- the mixture contained / V-acyl amino acids are precipitated by acidification and the precipitated solid optionally with the aid of a suitable organic see (co) solvent crystallized.
- this cleaning step also removes organic impurities, for example unreacted free amino acids.
- the isolation and drying of the purified solid means an additional expenditure of labor time and material, which leads to higher production costs.
- the object of the invention is the preparation of concentrated aqueous solutions of / V-acyl amino acids, which are obtained directly and without solids isolation from a reaction mixture.
- the aqueous concentrate should contain the / V-acyl-amino acid in high purity, while the by-products and waste products should be contained in the lowest possible concentration.
- the aqueous solution should also be chemically and physically stable over a wide temperature range, as odorless as possible and little colored.
- the basic crude product solution from a Schotten-Baumann reaction is acidified in the presence of an organic solvent.
- the solvent is selected from substances that are only slightly miscible with water, but at the same time form an azeotropic mixture with water.
- the N-acyl-amino acid passes into the organic solvent phase.
- the organic product solution is extracted with an aqueous solution of a base.
- the / V-acyl-amino acid passes as a water-soluble salt back into the aqueous solution.
- the solvent residues contained in the aqueous product solution are removed by azeotropic distillation.
- / V-acyl-amino acids are stronger acids than the alkyl-only fatty acids. Therefore, the fatty acids are in equilibrium at neutral pH in equilibrium partly as steam-volatile free carboxylic acids, while the / V-acyl amino acids are preferably present as non-volatile salts.
- a final pH adjustment to> 6.5 stabilizes the / V acyl amino acid as the carboxylic acid salt in the aqueous solution.
- the solutions obtained according to the invention are advantageous in many respects over the solids or salt-containing solutions known as prior art: they can easily be metered in as liquids and incorporated into liquid mixtures. They do not produce any or only slight pH changes.
- the solutions are practically free of inorganic salts, and thus show no negative interaction with salt-sensitive substances such as polymeric thickeners or salt-thickened surfactant gels.
- the solutions contain only a small amount of free alkylcarboxylic acids, which has a positive effect on their odor and their skin tolerance.
- the preparation of the solutions obtained according to the invention is inexpensive, since no solid / liquid T rennung is required.
- aminocarboxylic acid (amino acid) can be used as starting material for the synthesis of the / V-acyl-amino acid.
- Chiral amino acids can be used both as enantiomerically pure or diastereomerically pure compounds, as well as mixtures of different stereoisomers. Any additional functional groups present within the amino acids are optionally protected by suitable protecting groups. Furthermore, short peptides with up to 6 amino acids can be used.
- the amino acid component is selected from alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, glycylglycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, dihydroxyphenylalanine (DOPA), proline, serine, threonine, tryptophan , Tyrosine, valine, 3-aminopropionic acid (beta-alanine) and 4-aminobutyric acid (gamma-aminobutyric acid, GABA).
- the amino acid component is selected from glycine and glycylglycine.
- the fatty acid component is selected from any aliphatic fatty acid having a chain length of 6 to 22 carbons, preferably 6 to 12 carbons.
- the fatty acid can be saturated, monounsaturated or polyunsaturated. It can contain either one or two carboxylic acid functions.
- the / V -acyl amino acid contains at least one of the following radicals: hexanoyl (caproyl), heptanoyl (enanthoyl), octanoyl (capryloyl), nonanoyl (perlagonyl), decanoyl (caprinoyl), undecylenoyl, dodecanoyl (lauryl), tetradecanoyl (myristyl ), Hexadecanoyl (palmitoyl), heptadecanoyl (margarinoyl), octadecanoyl (stearyl), eicosanoyl (arachinoyl), docosanoyl (behenoyl), hexadecenoyl (palmitoleinoyl), octadecenoyl (oleyl), eicosenoyl (Gadoloyle radicals:
- the / V-acyl-amino acid contains one of the radicals octanoyl (capryloyl) and undecylenoyl.
- the carboxylic acid can be activated as an acid halide, as a mixed anhydride or as a symmetrical anhydride.
- the carboxylic acid is activated as the acid chloride.
- any acid can be used whose acidity is higher than that of the synthesized / V-acyl-amino acid.
- inorganic acids and / or their acid salts e.g. Hydrochloric acid, sulfuric acid, sodium hydrogen sulfate, potassium hydrogen sulfate, phosphoric acid, sodium dihydrogen phosphate, disodium hydrogen phosphate, potassium dihydrogen phosphate and / or dipotassium hydrogen phosphate.
- the adjusted pH is ⁇ 7.
- the pH is between 0 and 5, more preferably between 0.5 and 3.0.
- organic solvents for the aqueous work-up of the / V-acyl-amino acid solution it is possible to use any organic solvents which are immiscible or not completely miscible with water. Either individual solvents or solvent mixtures can be used.
- esters for example ethyl acetate, butyl acetate, isopropyl acetate, isobutyl acetate
- ethers for example ie / f-butylmethyl ether, diisopropyl ether, 2-methyltetrahydrofuran
- aromatic hydrocarbons for example toluene, xylene
- aliphatic hydrocarbons for example heptane, cyclohexane, Methylcyclohexane
- ketones eg ethyl methyl ketone, / so-butyl methyl ketone
- halogenated hydrocarbons eg dichloromethane, dichloroethane, chloroform
- alcohols eg n-butanol, isobutanol, amyl alcohol.
- Particularly preferably used are ethyl acetate, toluene, 2-methyltetrahydrofuran and
- phase separations in the course of the aqueous workup can be carried out at any temperature at which both phases are present as a liquid. Typically, this is the case at temperatures from -20 ° C to +100 ° C. Preferably, the phase separation is carried out at +10 ° C to +80 ° C, more preferably at +30 ° C to +60 ° C. The phase separation can also take place under overpressure.
- the azeotropic distillation to remove excess organic solvent may be at any pressure.
- the distillation can be carried out at atmospheric pressure (1013 mbar ⁇ 50 mbar) and / or in vacuo and / or under overpressure.
- any alkali or alkaline earth bases can be used. be set. Preference is given to using sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate and / or potassium hydrogencarbonate.
- the bases used can be used either as solids or as aqueous solutions.
- the pH of the / V-acyl amino acid solution prepared according to the invention can be between pH 5 and pH 14.
- the final product solution is adjusted to a pH between pH 6.5 and pH 8.5 inclusive.
- the concentration of the / V-acyl-amino acid in the prepared solutions according to the invention can be between 1% and 90%, preferably 10-50%, particularly preferably 20-40%.
- the values given are in terms of percent by weight based on the free N-acyl amino acid.
- the / V-acyl-amino acid is present mainly as a salt with the base used for the neutralization.
- some of the N-acyl amino acid may be present as the free carboxylic acid.
- aqueous solutions of / V-acyl amino acids are prepared by the described method.
- the solutions according to the invention are clear, stable and homogeneous over a wide temperature range. Crystallization of the solid components at low temperature occurs as little as a chemical decomposition of the components at higher temperature.
- the solutions according to the invention in a temperature range from -20 ° C to +80 ° C are physically and chemically stable.
- the aqueous solutions according to the invention are themselves conservative and thus stable to colonization or decomposition by microorganisms. Therefore, it is usually not necessary to protect the solutions of the invention with the help of additional preservatives.
- the solutions according to the invention may contain further auxiliaries. These may be, for example, preservatives, cosmetic solvents, surface-active substances (surfactants / emulsifiers) and / or water-soluble polyhydric alcohols.
- the solutions according to the invention can be used as raw materials in cosmetics and / or personal care products and / or pharmaceutical preparations. They can fulfill functions that generally contribute to a positive influence on age-related and / or environmental skin or hair changes. They can be used, for example, as preservatives, deodorants, anti-acne agents, anti-dandruff agents, skin light, enzyme inhibitor and / or pH regulator can be used. Other possible applications without excluding character include the use as a conditioner, foam intensifier, (co) emulsifier and / or (co) surfactant, enzyme inhibitor, light and UV protection, and for the regulation of sebum production and / or influencing the rheology or Viscosity.
- the solution according to the invention it is also possible to produce a product, in particular a cosmetic and / or pharmaceutical and / or dermatological and / or hygienic product, containing a solution as explained above.
- the solution according to the invention is used in cosmetic and / or pharmaceutical and / or dermatological and / or hygienic products.
- hygienic preparation or “hygienic product” in particular household or cleaning products, and fragrance preparations are understood.
- the addition of the solutions according to the invention to the cosmetic and / or pharmaceutical and / or dermatological and / or hygienic product may take place at any time during production, e.g. during the production of an aqueous phase or at the end of the production process.
- solutions according to the invention are also used in a product, in particular a cosmetic or dermatological product, containing the solutions according to the invention, the product containing 0.05-10.0% by weight of at least one / V-acyl amino acid.
- the respective product can be present in any form, in particular as:
- the 30% aqueous capryloylglycine solution meets the A criteria of a preservative loading test according to ISO 1 1930. Thus, this solution is protected against microbiological contamination. An additional preservative is not required.
- phase A The raw materials of phase A are taken up with stirring in water.
- the solution according to the invention is added (phase B).
- the thickener (phase C) is added with vigorous stirring.
- the ingredients of phase D are added sequentially, followed by common salt (phase E).
- the mixture is stirred until the solid is completely dissolved.
- the pH is adjusted (phase F).
- the shampoo meets the A criteria of a preservative loading test according to ISO 1 1930.
- Methylcellulose is added with stirring at RT in water. The pH should not exceed 7.5 (phase A).
- Pentiol Green + and xanthan gum are mixed (Phase B) and the mixture is added to Phase A. The mixture is stirred until homogeneous.
- the solution according to Example 1 is added, followed by a little sodium hydroxide solution (phase C). The mixture is stirred for 15-20 minutes until fully thickened.
- Phase D surfactants are added with stirring in the order listed.
- the raw materials of phase E are added successively with stirring in the order given.
- the pH is adjusted. The product meets the A criteria of a preservative loading test according to ISO 1 1930.
- Raw Material Suppliers 1) Minasolve, 2) Jungbunzlauer, 3) BASF, 4) AAK, 5) Caesar & Loretz
- phase A The solution according to the invention (phase B) is added and the mixture is heated to 75-80 ° C.
- phase C is mixed and heated to 75-80 ° C.
- Phase C is added to Phase A + B while mixing with an Ultra-Turrax.
- the emulsion is stirred for 3 minutes at a high shear rate and then for a further 30 minutes with a propeller stirrer. During cooling, the stirrer speed is lowered.
- T ⁇ 40 ° C tocopherol is added (phase D).
- phase E the pH is adjusted (phase E).
- the product meets the A criteria of a preservative loading test according to ISO 1 1930.
- Caprocine (1) Capryloyl Glycine 2.0 Emulgade PL 68/50 (3) Cetearyl Glucoside (and) Cetearyl Alcohol 5.0 c Lipex Sheasoft (4) Butyrospermum Parkii (Shea) Butter 3.0
- Jojoba Oil (5) Simmondsia Chinensis (Jojoba) Seed 0/7 3.0
- Hazelnut Seed Oil (5) Corylus Avellana (Hazel) Seed 0/7 3.0
- Raw Material Suppliers 1) Minasolve, 2) Jungbunzlauer, 3) BASF, 4) AAK, 5) Caesar & Loretz
- Xanthan gum is mixed with Pentiol Green + and then added with stirring in water. The mixture is stirred until homogeneous (phase A).
- phase A demineralized water is initially charged and mixed with aqueous sodium hydroxide solution. Then solid capryloyl glycine is added with stirring. The mixture is stirred until a clear solution has formed (phase B).
- Phase B is metered to Phase A and the mixture is then heated to 75-80 ° C.
- phase C is mixed and heated to 75-80 ° C. Phase C is added to Phase A + B while mixing with an Ultra-Turrax.
- the emulsion is stirred for 3 minutes at a high shear rate and then for a further 30 minutes with a propeller stirrer. During cooling, the stirrer speed is lowered. At T ⁇ 40 ° C tocopherol is added (phase D). At room temperature, the pH is adjusted (phase E). The product meets the A criteria of a preservative loading test according to ISO 1 1930.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016104205.6A DE102016104205A1 (en) | 2016-03-08 | 2016-03-08 | Aqueous solutions of N-acyl amino acids |
PCT/EP2017/053855 WO2017153161A1 (en) | 2016-03-08 | 2017-02-21 | Aqueous n-acyl amino acid solutions |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3426631A1 true EP3426631A1 (en) | 2019-01-16 |
Family
ID=58185499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17707498.6A Withdrawn EP3426631A1 (en) | 2016-03-08 | 2017-02-21 | Aqueous n-acyl amino acid solutions |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190091124A1 (en) |
EP (1) | EP3426631A1 (en) |
CN (1) | CN108779065A (en) |
DE (1) | DE102016104205A1 (en) |
MA (1) | MA43685A (en) |
WO (1) | WO2017153161A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3075197B1 (en) * | 2017-12-20 | 2019-11-15 | Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic | NOVEL COMPOSITION OF LIPOAMINOACIDES AND DIOLS, PROCESS FOR THEIR PREPARATION AND COSMETIC OR PHARMACEUTICAL COMPOSITION RESULTING THEREFROM |
CN109369439B (en) * | 2018-12-06 | 2021-04-16 | 盐城工学院 | Preparation method of N-acyl amino acid type surfactant |
CN110938023A (en) * | 2019-12-23 | 2020-03-31 | 张家港格瑞特化学有限公司 | Preparation method of fatty acyl taurine surfactant |
FR3130576A1 (en) * | 2021-12-21 | 2023-06-23 | L'oreal | Aqueous cosmetic composition comprising vanillin or one of its derivatives, a nonionic surfactant, and optionally at least one additional antimicrobial |
CN115160169B (en) * | 2022-07-25 | 2024-04-16 | 湖州欧利生物科技有限公司 | Production process of cocoyl glycinate surfactant |
CN116172888B (en) * | 2022-12-21 | 2024-07-02 | 陕西畅想制药有限公司 | Composition containing amino acid derivatives for regulating skin microecology |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT490450A (en) * | 1951-07-19 | |||
US5710295A (en) * | 1995-06-06 | 1998-01-20 | Hampshire Chemical Corp. | Preparation of alkali metal acyl amino acids |
US5762765A (en) * | 1997-04-14 | 1998-06-09 | Berg; Lloyd | Separation of ethanol, isopropanol and water mixtures by azeotropic distillation |
FR2771632B1 (en) | 1997-12-01 | 2000-03-17 | Seppic Sa | SYNERGISTIC COMPOSITION COMPRISING AT LEAST ONE LIPOAMINOACID AND AT LEAST ONE GLYCOL; APPLICATION IN COSMETICS |
FR2771633B1 (en) * | 1997-12-01 | 2000-01-14 | Seppic Sa | SYNERGISTIC COMPOSITION COMPRISING AT LEAST ONE N-OCTANYL AMINOACIDE AND AT LEAST ONE N-UNDECYLENOYL AMINOACIDE; APPLICATION IN COSMETICS |
ITMI20041567A1 (en) | 2004-07-30 | 2004-10-30 | Maycos Italiana Di Comini Miro | "N-ACYLATED DERIVATIVES OF BICARBOXYLIC ACIDS WITH AMINO ACIDS AND WITH HYDROLYZED VEGETABLE PROTEINS AND THEIR APPLICATION IN COSMETIC, DERMO-PHARMACEUTICAL AND PHARMACEUTICAL PRODUCTS" |
JP2008105945A (en) * | 2005-02-07 | 2008-05-08 | Ajinomoto Co Inc | Acylamide compound having action of promoting or inducing secretion of adiponectin |
FR2929275B1 (en) * | 2008-03-28 | 2011-09-23 | Seppic Sa | PROCESS FOR THE CONTINUOUS SYNTHESIS OF AN N-ACYL COMPOUND INSTALLATION FOR IMPLEMENTING THE METHOD |
US20130101530A1 (en) * | 2011-10-25 | 2013-04-25 | Galaxy Surfactants Ltd. | Antimicrobial preservative compositions for personal care products |
-
2016
- 2016-03-08 DE DE102016104205.6A patent/DE102016104205A1/en not_active Withdrawn
-
2017
- 2017-02-21 WO PCT/EP2017/053855 patent/WO2017153161A1/en active Application Filing
- 2017-02-21 MA MA043685A patent/MA43685A/en unknown
- 2017-02-21 CN CN201780016333.5A patent/CN108779065A/en active Pending
- 2017-02-21 EP EP17707498.6A patent/EP3426631A1/en not_active Withdrawn
- 2017-02-21 US US16/083,436 patent/US20190091124A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE102016104205A1 (en) | 2017-09-14 |
US20190091124A1 (en) | 2019-03-28 |
MA43685A (en) | 2018-11-28 |
CN108779065A (en) | 2018-11-09 |
WO2017153161A1 (en) | 2017-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017153161A1 (en) | Aqueous n-acyl amino acid solutions | |
EP0556660B1 (en) | Utilisation of fatty alpha-hydroxy acids | |
DE3212448C2 (en) | Agents containing N-acylates of α-amino acids | |
DE69508189T2 (en) | Process for the preparation of amphoacetate surfactants | |
CA2073353C (en) | Glycerol-derived non ionic amphiphilic compounds, a process for their preparation, corresponding intermediary compounds and compositions containing said compounds | |
DE2222733A1 (en) | New chitoxsan derivatives and processes for their production | |
DE69522372T2 (en) | Polyaspartic acid derivatives and process for their preparation | |
DE3818293C2 (en) | Process for the preparation of nonionic surfactants, their use and preparations using the same | |
DE112007001469T5 (en) | Collagen Synthesis Promoter Containing Zinc as an Active Ingredient | |
DE69202098T2 (en) | N-pentadecyl nicotinate N-oxide and hair restorer containing it. | |
EP3478655A1 (en) | Method for producing surfactants | |
DE3032612A1 (en) | IF REQUIRED, SULFIED PARTIALESTERS OF MULTI-VALUE ALCOHOLS - METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SKIN-FRIENDLY, NON-IONOGENIC AND / OR ANION-ACTIVE SURFACE-ACTIVE SUBSTANCES | |
DE2349707A1 (en) | N- (MERCAPTOACYL) -AMINO ACIDS, PROCESS FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
CA2358118A1 (en) | Process for producing long chain n-acyl acidic amino acid | |
DE69209505T2 (en) | LIPOAMINO ACIDS, THEIR PRODUCTION AND USE | |
DE69309622T2 (en) | Amino acid derivatives represented by acylation of protein hydrolipates and antimicrobial, antiparasitic or cosmetic compositions containing them | |
EP0864563B1 (en) | N-Acyl-hydroxy amino acid esters used to protect skin and hair | |
DE69823187T2 (en) | A COMPOSITION COMPRISING AN N-ANDECYLENOYL AMINO-SUBSTRATE; APPLICATION IN COSMETICS | |
EP2473164A2 (en) | Antimicrobial ether guanidines | |
DE4016517A1 (en) | ALKYLESTER OF N-CARBOALKYLOXYAMINO-11-ANDECANSAURES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS THICKENERS | |
EP0081771A1 (en) | Heterocyclic compounds, their preparation, cosmetic preparations containing them and their use in hair and skin care | |
WO2000021500A1 (en) | Perfume composition having a sun-block and tanning effect | |
DE69018258T2 (en) | Phospholipidic liposomes containing active ingredients and process for their preparation. | |
DE69918398T2 (en) | 2-amino-4-alkylamino-pyrimidin-3-oxide | |
DE102010055769A1 (en) | Low viscosity W / O containing one or more glucosylglycerides and one or more electrolytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180925 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RAV | Requested validation state of the european patent: fee paid |
Extension state: MA Effective date: 20180925 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MINASOLVE SAS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200406 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20200818 |